Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amelia (formerly IPsoft) is a leading enterprise artificial intelligence company specializing in conversational AI and automation solutions for the healthcare and life sciences sectors. Its flagship platform, Amelia, serves as a sophisticated digital assistant capable of managing complex administrative and operational tasks such as patient intake, appointment scheduling, and insurance claims processing. By leveraging advanced natural language processing and machine learning, the company's 'Amelia Health Agent' aims to reduce the administrative burden on clinical staff and improve patient engagement through human-like interactions. In August 2024, Amelia was acquired by SoundHound AI, a move that integrated its enterprise-grade conversational AI with SoundHound's voice AI technology. The company's solutions are widely used by healthcare providers and insurers to streamline patient journeys and optimize operational efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IPsoft.